Your browser doesn't support javascript.
loading
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
Denu, Ryan A; Yang, Richard K; Lazar, Alexander J; Patel, Shalin S; Lewis, Valerae O; Roszik, Jason; Livingston, J Andrew; Wang, Wei-Lien; Shaw, Kenna R; Ratan, Ravin; Zarzour, Maria A; Bird, Justin; Raza, Shaan; Akdemir, Kadir C; Rodon Ahnert, Jordi; Subbiah, Vivek; Patel, Shreyaskumar; Conley, Anthony P.
Afiliación
  • Denu RA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yang RK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel SS; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lewis VO; Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Roszik J; Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Livingston JA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang WL; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shaw KR; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ratan R; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zarzour MA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bird J; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Raza S; Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Akdemir KC; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rodon Ahnert J; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 29(23): 4844-4852, 2023 12 01.
Article en En | MEDLINE | ID: mdl-37747813
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Condrosarcoma Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Condrosarcoma Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos